Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
206.80B | 192.38B | 140.79B | 173.83B | 141.74B | Gross Profit |
37.81B | 22.03B | 24.99B | 16.96B | 15.91B | EBIT |
1.94B | -5.74B | -17.82B | -45.65B | -13.79B | EBITDA |
5.76B | 4.99B | -18.44B | -39.61B | -7.32B | Net Income Common Stockholders |
1.26B | 493.51M | -23.78B | -49.33B | -10.61B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
51.84B | 47.61B | 38.40B | 56.77B | 56.77B | Total Assets |
143.89B | 143.83B | 131.21B | 153.00B | 147.27B | Total Debt |
12.66B | 9.70B | 6.35B | 9.69B | 9.13B | Net Debt |
102.81M | -17.61B | -14.51B | -33.74B | -10.24B | Total Liabilities |
45.19B | 30.78B | 21.79B | 27.55B | 30.12B | Stockholders Equity |
98.58B | 97.79B | 95.28B | 112.05B | 113.62B |
Cash Flow | Free Cash Flow | |||
2.85B | 5.30B | -12.11B | -20.03B | -4.66B | Operating Cash Flow |
6.45B | 7.64B | -9.55B | -13.41B | 1.14B | Investing Cash Flow |
-14.14B | -4.48B | -11.03B | 1.15B | -1.95B | Financing Cash Flow |
-6.60B | 3.54B | -3.55B | 35.19B | 9.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $12.79B | 24.59 | 10.30% | 0.78% | 28.87% | 57.72% | |
70 Outperform | $6.60B | 114.58 | 8.56% | ― | 27.32% | ― | |
67 Neutral | $19.07B | 835.71 | 0.38% | ― | 17.24% | ― | |
62 Neutral | $11.93B | 10.60 | -7.51% | 3.00% | 7.40% | -8.09% | |
59 Neutral | $23.24B | 93.45 | 0.19% | ― | 5.92% | 36.65% |